IL2 and neoplasm: One mechanism of action exploited by immunotherapy is the activation or re-activation of cytotoxic T lymphocytes against cancer cells through the administration of tumor vaccines, cytokines such as interleukin-2, or through the adoptive transfer of tumor-infiltrating T cells (TILs) [203,204].